Please login to the form below
AMR
This page shows the latest AMR news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
Europe launches antimicrobial research ‘Accelerator’. A new Antimicrobial Resistance (AMR) Accelerator Programme has been unveiled by the EU and pharma-funded Innovative Medicines Initiative (IMI).
Latest news
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
Europe launches antimicrobial research ‘Accelerator’. A new Antimicrobial Resistance (AMR) Accelerator Programme has been unveiled by the EU and pharma-funded Innovative Medicines Initiative (IMI).
-
Evotec says Sanofi deal makes it anti-infectives powerhouse
regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.”It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,
-
Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more
AMR. UK pledges £30m to fight antimicrobial resistance. The UK has taken a lead in co-ordinating international action to counter antimicrobial resistance in the last few years, and has just ... A further £5m will be spent on a partnership with
-
Profit: the ugly, dirty truth?
On anti-microbial resistance (AMR), the incentive structures offered up by governments globally so far have lacked ambition and fundamental insight into how the market drives pharma to invest and take ... We have a global declaration on AMR, which has a
-
Sanofi taps Evotec for new anti-infectives drive
Earlier this year, an independent report looking at the pharma industry’s efforts to tackle antimicrobial resistance (AMR) said the sector is still not on track to avert a potential healthcare
More from news
Approximately 5 fully matching, plus 18 partially matching documents found.
Latest Intelligence
-
Rules of engagement
Only one-fifth were aware of its abbreviated form ‘AMR’. By contrast, more than two-thirds knew of the terms ‘antibiotic resistance’or ‘drug resistance’.
-
The threat of antimicrobial resistance
A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the global threat from antimicrobial resistance.
-
The AMR threat
The roots of the AMR problem lay in over-prescribing and the use of antibiotics for growth promotion in the agricultural sector outside Europe. ... Given the strength of the government's backing for the fight against AMR, the Review can certainly claim
-
Cubist: Meeting the challenge in antibiotics
AMR is something that is increasing and it doesn't stop at borders - we see big resistance problems in Europe. ... Several other companies are signed up to the IMI's efforts in AMR, including GlaxoSmithKline, AstraZeneca, Janssen and Sanofi, suggesting
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Antibiotic Resistance: Alarm bells ring louder than ever
where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... How can this be prevented? AMR is a complex, global issue and corrective action is only possible if we accurately know and understand what
-
amr
amr. amr is a full-service market research agency and we are passionate about the research that we do.
-
Market research
amr is a full-service market research agency and we are passionate about the research that we do.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
-
Systematic Review Lead- London
-
Negotiable
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior Medical Writer
-
Salary is DOE
- Medical Writers Required - Hertfordshire
-
Competitive
- Account Director or Senior Account Director
-
Salary TBC
-
Associate Scientific Director
-
Salary TBC
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
Wordbird
Wordbird is a healthcare communications agency with creative, compelling copy at its heart....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
